Steris (STE) EBITDA Margin Growth (3y) (2021 - 2026)
Powered by 
Analysis
Steris (STE) EBITDA Margin Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.43 Bn | 177.83 Bn | 7.27 Bn | -201.00 |
| 2 | Intuitive Surgical | 124.55 Bn | 119.33 Bn | 1.96 Bn | 722.00 |
| 3 | Medtronic | 117.91 Bn | 109.10 Bn | 6.34 Bn | 162.00 |
| 4 | Stryker | 105.51 Bn | 102.03 Bn | 4.50 Bn | 586.00 |
| 5 | Boston Scientific | 66.23 Bn | 65.69 Bn | 3.85 Bn | 736.00 |
| 6 | Edwards Lifesciences | 49.46 Bn | 45.21 Bn | 1.35 Bn | 887.00 |
| 7 | Alcon | 33.87 Bn | 32.41 Bn | 1.68 Bn | -1,075.00 |
| 8 | Dexcom | 32.08 Bn | 30.13 Bn | 830.00 Mn | 963.00 |
| 9 | Steris | 21.05 Bn | 20.56 Bn | 684.20 Mn | 244.00 |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn | -265.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 244.00 |
| Mar 31, 2026 | -3,846.00 |
| Dec 31, 2025 | 111.00 |
| Sep 30, 2025 | 4,629.00 |
| Jun 30, 2025 | 262.00 |
| Mar 31, 2025 | 270.00 |
| Dec 31, 2024 | 111.00 |
| Sep 30, 2024 | 680.00 |
| Jun 30, 2024 | 1,302.00 |
| Mar 31, 2024 | -99.00 |
| Dec 31, 2023 | -72.00 |
| Sep 30, 2023 | -321.00 |
| Jun 30, 2023 | -60.00 |
| Mar 31, 2023 | 3,924.00 |
| Dec 31, 2022 | -124.00 |
| Sep 30, 2022 | -4,529.00 |
| Jun 30, 2022 | -74.00 |
| Mar 31, 2022 | -638.00 |
| Dec 31, 2021 | 679.00 |
| Sep 30, 2021 | -596.00 |